Scarica l'app Stockscreener
27.56
2.49%
-0.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$28.32
Aprire:
$28.05
Volume 24 ore:
57,078
Relative Volume:
0.32
Capitalizzazione di mercato:
$394.83M
Reddito:
$138.20M
Utile/perdita netta:
$5.52M
Rapporto P/E:
72.53
EPS:
0.38
Flusso di cassa netto:
$9.86M
1 W Prestazione:
+0.93%
1M Prestazione:
-5.17%
6M Prestazione:
-0.09%
1 anno Prestazione:
-26.50%
Intervallo 1D:
$27.40
$28.12
Intervallo di 1 settimana:
$26.73
$28.67
Portata 52W:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Nome
Surmodics Inc
Settore
Industria
Telefono
(952) 500-7000
Indirizzo
9924 W 74TH ST, EDEN PRAIRIE, MN
Confronta SRDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
27.61 | 404.91M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
125.26 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.53 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.54 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.10 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.13 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Aggiornamento | Lake Street | Hold → Buy |
| 2023-06-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-02-13 | Downgrade | Needham | Buy → Hold |
| 2020-07-23 | Aggiornamento | Needham | Hold → Buy |
| 2019-12-11 | Downgrade | Needham | Buy → Hold |
| 2019-11-01 | Downgrade | Lake Street | Buy → Hold |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Lake Street | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-02-21 | Reiterato | Needham | Buy |
| 2018-05-16 | Reiterato | Needham | Buy |
| 2018-03-01 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-02-28 | Reiterato | Lake Street | Buy |
| 2018-02-28 | Iniziato | Needham | Buy |
| 2017-07-14 | Iniziato | Lake Street | Buy |
| 2016-11-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Downgrade | Sidoti | Buy → Neutral |
| 2016-05-03 | Reiterato | Barrington Research | Outperform |
| 2015-08-06 | Reiterato | Barrington Research | Outperform |
| 2015-03-27 | Iniziato | Dougherty & Company | Buy |
| 2014-02-25 | Iniziato | Laidlaw | Buy |
| 2013-08-01 | Aggiornamento | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Surmodics Inc Borsa (SRDX) Ultime notizie
Surmodics (SRDX) Releases Positive Results from PROWL Registry S - GuruFocus
Surmodics reports high success rate for Pounce thrombectomy device - Investing.com
Will earnings trigger a reversal in Surmodics Inc.July 2025 Review & Consistent Income Trade Ideas - newser.com
Surmodics shares data from 160 patients in PROWL registry using Pounce for real-world limb ischemia - MarketScreener
Surmodics (NASDAQ: SRDX) PROWL Registry Shows 0.6% Device-Related MAEs, 94.8% Flow Restoration - Stock Titan
Key metrics from Surmodics Inc.’s quarterly dataPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Should you wait for a breakout in Surmodics Inc.2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3 - BioSpace
Discipline and Rules-Based Execution in SRDX Response - news.stocktradersdaily.com
Surmodics to present updated data on Pounce thrombectomy system By Investing.com - Investing.com Nigeria
Surmodics spotlights unique arterial thrombotic study at VIVA25 - Traders Union
What earnings revisions data tells us about Surmodics Inc.Weekly Risk Summary & Community Verified Trade Signals - newser.com
Can Surmodics Inc. stock deliver sustainable ROE2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
Is it time to cut losses on Surmodics Inc.Portfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Surmodics to present updated data on Pounce thrombectomy system - Investing.com
Y Intercept Hong Kong Ltd Buys Shares of 42,975 Surmodics, Inc. $SRDX - MarketBeat
Can Surmodics Inc. stock reach $100 price targetJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
Is Surmodics Inc. stock resilient to inflationWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Will Surmodics Inc. stock return to pre crisis levelsWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
How to interpret RSI for Surmodics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Is Surmodics Inc. stock a safe investment in uncertain markets2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
How institutional ownership impacts Surmodics Inc. stock2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-01 01:11:15 - newser.com
Is Surmodics Inc. stock entering bullish territoryJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Regression analysis insights on Surmodics Inc. performanceEarnings Beat & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-31 04:30:06 - newser.com
Published on: 2025-10-31 04:03:38 - newser.com
Surmodics (SRDX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform - BioSpace
Surmodics (SRDX) PROWL Study Highlights Success in Thrombectomy Procedures - GuruFocus
Surmodics, Inc. (NASDAQ:SRDX) Given Average Rating of "Hold" by Analysts - MarketBeat
Surmodics Inc Azioni (SRDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surmodics Inc Azioni (SRDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
0.78%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):